We first characterized the expression of CD38 on immune cells derived from healthy donors as well as from MM patients, finding that the greatest proportion of CD38+ cells and highest expression levels were observed with NK cells and monocytes. The gene discussed is CD38; the disease is Miyoshi myopathy.